Global Dental Sleep Medicine Market, By Type (Diagnostic and Treatment), Treatment & Diagnostics (Positive Airway Pressure (Pap) Therapy, Oral and Nasal Devices, Airway Systems, Other Devices, Drugs, Surgery, Polysomnography and Polygraphy, and Oximetry and Actigraph), Age Group (Pediatric, Adult, and Geriatric), End User (Hospitals, Sleep Laboratories, Home, and Others) – Industry Trends and Forecast to 2031.
Dental Sleep Medicine Market Analysis and Size
The dental sleep medicine market has witnessed significant growth in recent years, driven by rising awareness of sleep-related breathing disorders such as obstructive sleep apnea (OSA) and an increasing preference for non-invasive treatment options. This market encompasses a range of oral appliances and therapies designed to manage OSA and other sleep disorders through dental interventions. The demand for dental sleep medicine solutions is fueled by factors such as the growing prevalence of sleep apnea worldwide, coupled with advancements in dental technology that enable more precise and effective treatment options. In addition, collaborations between dental professionals and sleep medicine specialists have enhanced diagnostic capabilities and treatment outcomes, further boosting market expansion. As the field continues to evolve with ongoing research and technological innovations, the dental sleep medicine market is expected to continue its growth trajectory, offering promising opportunities for manufacturers, dental clinics, and healthcare providers globally.
Global dental sleep medicine market size was valued at USD 6.69 billion in 2023 and is projected to reach USD 10.04 billion by 2031, with a CAGR of 5.21% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Diagnostic and Treatment), Treatment & Diagnostics (Positive Airway Pressure (Pap) Therapy, Oral and Nasal Devices, Airway Systems, Other Devices, Drugs, Surgery, Polysomnography and Polygraphy, and Oximetry and Actigraph), Age Group (Pediatric, Adult, and Geriatric), End User (Hospitals, Sleep Laboratories, Home, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
Koninklijke Philips N.V. (Netherlands), ResMed (Australia), Fisher & Paykel Healthcare Limited (New Zealand), DeVilbiss Healthcare LLC (U.S.), Curative Medical (U.S.), Apex Dental Sleep Lab (U.S.), BMC Medical Co., Ltd. (China), BD (Becton, Dickinson and Company) (U.S.), Cadwell Industries Inc. (U.S.), Invacare Corporation (U.S.), Compumedics Limited (Australia), Braebon Medical Corporation (Canada), General Electric (U.S.), SomnoMed (Australia), Henry Schein, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Dental sleep medicine is a specialized field within dentistry that focuses on the diagnosis, treatment, and management of sleep-related breathing disorders, particularly obstructive sleep apnea (OSA). Dentists trained in dental sleep medicine work collaboratively with sleep physicians to provide oral appliance therapy as an alternative treatment to continuous positive airway pressure (CPAP) machines. These oral appliances are custom-fit devices designed to help keep the airway open during sleep, improving breathing and reducing the severity of sleep apnea symptoms.
Dental Sleep Medicine Market Dynamics
Drivers
- Increasing Awareness Diagnosis
The growing awareness of sleep disorders, particularly obstructive sleep apnea (OSA), has significantly bolstered the demand for dental sleep medicine solutions. As more individuals recognize the symptoms and risks associated with untreated OSA, there is a heightened interest in seeking effective treatment options beyond traditional methods like CPAP machines. This increased awareness not only drives patient demand but also encourages healthcare providers to integrate dental sleep medicine into their diagnostic and treatment protocols, thereby expanding the market for oral appliances and related services.
- Non-Invasive Treatment Options
Oral appliances represent a pivotal advancement in non-invasive treatment options for sleep-related breathing disorders, offering a viable alternative to dental sleep medicine appliances. These devices are favored by patients seeking more comfortable and user-friendly solutions for managing conditions such as OSA. Unlike CPAP, which requires wearing a mask during sleep and can cause discomfort or claustrophobia, oral appliances are custom-fit devices that reposition the jaw and tongue to maintain an open airway. This comfort and ease of use contribute to higher patient compliance rates, thereby enhancing the appeal and market acceptance of dental sleep medicine as a whole.
Opportunities
- Collaboration between Dental and Sleep Medicine Specialists
Collaborative efforts between dental professionals and sleep physicians are instrumental in advancing the field of dental sleep medicine. By pooling their expertise, these specialists can leverage combined diagnostic tools and treatment approaches to provide comprehensive care for patients with sleep disorders. This collaboration not only enhances diagnostic accuracy but also improves the overall management of conditions like OSA through tailored treatment plans that may include oral appliances. Such integrated care models are critical for optimizing patient outcomes and expanding the scope of dental sleep medicine.
- Increasing Healthcare Expenditure
The rising global healthcare expenditure, coupled with expanded insurance coverage for dental sleep medicine treatments, is a significant driver of market growth. As healthcare systems allocate more resources towards preventative and specialized care, there is greater accessibility to oral appliances and related services for patients with sleep-related breathing disorders. This financial support not only increases patient affordability but also encourages healthcare providers to invest in advanced technologies and infrastructure necessary for delivering high-quality dental sleep medicine solutions, creating new market opportunities.
Restraints/Challenges
- Limited Reimbursement Policies
Inconsistent reimbursement policies and limited coverage for dental sleep medicine treatments in certain regions pose challenges to market growth. These policies may deter healthcare providers from offering comprehensive oral appliance therapy or hinder patient access to affordable treatment options. Addressing these reimbursement issues requires advocacy efforts to standardize coverage guidelines and highlight the cost-effectiveness of dental sleep medicine in managing sleep disorders like OSA.
- Patient Compliance Issues
Challenges related to patient compliance with oral appliance therapy represent another barrier to market growth within dental sleep medicine. Despite the comfort and convenience offered by oral appliances compared to CPAP machines, some patients may experience initial discomfort or difficulty adjusting to the devices. This could lead to lower adoption rates and suboptimal treatment outcomes if compliance issues are not effectively addressed and present challenges for the market.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2023, Apnimed, Inc., a clinical-stage pharmaceutical company specializing in oral pharmacologic therapies for obstructive sleep apnea (OSA) and other sleep disorders, disclosed a new collaboration. They have entered into a joint venture with Shionogi & Co., Ltd., a prominent global pharmaceutical company headquartered in Japan. This partnership aims to pioneer innovative pharmacologic treatments for obstructive sleep apnea (OSA) and other sleep-related conditions
- In June 2023, Torch Dental, a prominent platform for dental procurement, ordering, and expenditure management, partnered with the American Academy of Dental Sleep Medicine (AADSM). This collaboration aims to provide unique advantages exclusively for AADSM members, marking a significant achievement as both entities merge their knowledge to enhance dental sleep medicine through innovative solutions, education, and practice management
- In December 2022, New West Dental Lab introduced the EndSnorZ Sleep Appliance, expanding its range of mandibular advancement devices (MADs). This new addition offers dentists a customizable, patient-specific solution using 3D-printing technology. The appliance is designed to treat snoring and obstructive sleep apnea (OSA), featuring adjustability in increments of 0.5 mm over a range of 10 mm, providing precise and tailored treatment options for patients
Dental Sleep Medicine Market Scope
The market is segmented on the basis of type, treatment & diagnostics, age group, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Diagnostic
- Treatment
Treatment & Diagnostics
- Positive Airway Pressure (PAP) Therapy
- Oral and Nasal Devices
- Airway Systems
- Other Devices
- Drugs
- Surgery
- Polysomnography and Polygraphy
- Oximetry and Actigraph
Age Group
- Pediatric
- Adult
- Geriatric
End User
- Hospitals
- Sleep Laboratories
- Home
- Others
Dental Sleep Medicine Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, treatment & diagnostics, age group, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to favorable reimbursement policies, extensive awareness regarding dental sleep medicine, and a robust presence of manufacturers, suppliers, and distributors, particularly in the U.S..
Asia-Pacific is expected to witness significant growth during the forecast period due to increased healthcare spending from both governmental and private sectors, coupled with a rising number of patients seeking treatment for sleep disorders like insomnia and sleep apnea. In addition, the expanding medical tourism sector in Asia Pacific is anticipated to further stimulate demand for dental devices in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Dental Sleep Medicine Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Koninklijke Philips N.V. (Netherlands)
- ResMed (Australia)
- Fisher & Paykel Healthcare Limited (New Zealand)
- DeVilbiss Healthcare LLC (U.S.)
- Curative Medical (U.S.)
- Apex Dental Sleep Lab (U.S.)
- BMC Medical Co., Ltd. (China)
- BD (Becton, Dickinson and Company) (U.S.)
- Cadwell Industries Inc. (U.S.)
- Invacare Corporation (U.S.)
- Compumedics Limited (Australia)
- Braebon Medical Corporation (Canada)
- General Electric (U.S.)
- SomnoMed (Australia)
- Henry Schein, Inc. (U.S.)
SKU-